>Европейский рынок тестирования в местах оказания медицинской помощи (POCT), побочные продукты (инструменты, расходные материалы и реагенты и другие), применение (уровень глюкозы в крови, мониторинг сердечной деятельности, коагуляция, анализ цельной крови, мониторинг основных показателей жизнедеятельности, тестирование на инфекционные заболевания , анализ мочи, тестирование на холестерин и другие), конечный пользователь (лаборатории, больницы, клиники, амбулаторные центры, уход на дому, дома престарелых, аптеки и другие), способ тестирования (тестирование по рецепту и безрецептурное тестирование), канал сбыта (прямые продажи, сторонние дистрибьюторы и онлайн-продажи) — тенденции отрасли и прогноз до 2029 года.
Анализ и аналитика европейского рынка тестирования в местах оказания медицинской помощи (POCT)
Тестирование в месте оказания помощи (POCT) характеризуется как тестирование, которое может проводиться в непосредственной близости от пациента, где медицинское решение может быть принято немедленно, включая результаты и мониторинг. Рост распространенности инфекционных и хронических заболеваний, улучшение показателей обращаемости за диагностикой и растущее предпочтение тестированию на дому являются одними из основных факторов, обуславливающих рост рынка.
Однако отсутствие соответствия результатам испытаний, полученным в лабораториях, высокая стоимость и нехватка обученного персонала — вот некоторые из проблем, сдерживающих рост рынка.
Ожидается, что рынок тестирования в местах оказания медицинской помощи (POCT) в Европе будет расти в прогнозируемый период с 2022 по 2029 год. По данным Data Bridge Market Research, среднегодовой темп роста рынка составит 8,8% в прогнозируемый период с 2022 по 2029 год, а к 2029 году его объем, как ожидается, достигнет 13 085,33 млн долларов США.
Отчет Метрика |
Подробности |
Прогнозируемый период |
2022-2029 |
Базовый год |
2021 |
Исторический год |
2020 (Можно настроить на 2019-2014) |
Количественные единицы |
Доход в млн. долл. США |
Охваченные сегменты |
По видам продукции (инструменты, расходные материалы и реагенты и др.), Применение (уровень глюкозы в крови, мониторинг работы сердца, коагуляция, анализ цельной крови, мониторинг основных показателей жизнедеятельности, тестирование на инфекционные заболевания, анализ мочи, тестирование на холестерин и др.), Конечный пользователь (лаборатории, больницы, клиники, амбулаторные центры, уход на дому, дома престарелых, аптеки и др.), Способ тестирования (тестирование по рецепту и безрецептурное тестирование), Канал распространения (прямые продажи, сторонние дистрибьюторы и онлайн-продажи) |
Страны, охваченные |
Германия, Франция, Великобритания, Италия, Испания, Нидерланды, Россия, Швейцария, Турция, Бельгия и остальная Европа |
Охваченные участники рынка |
Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Quidel Corporation Trividia Health, Inc., Nova Biomedical, PTS Diagnostics, Trinity Biotech, LumiraDx, Sekisui Diagnostics, Chembio Diagnostics, Inc., BD, Thermo Fisher Scientific Inc., Abbott, Danaher, binx health, inc, QuantuMDx Group Ltd., Werfen, Thermo Fisher Scientific, Abaxis, EKF Diagnostics и Sysmex Europe SE |
Определение рынка
Point of Care Testing (POCT) is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within a few minutes as compared to hours. Currently, there are various products available that provide rapid and accurate results and help in patient’s better outcomes which is expected to provide various other opportunities for the market growth. However, lack of alignment in lab results and high cost of POCT products are expected to restrain the market growth in the forecast period.
Europe point of care testing (POCT) market report provides details of market share, new developments, product pipeline analysis and impact of domestic and localized market players that analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Europe Point of Care Testing (POCT) Market Dynamics
Drivers
- Increasing prevalence of infectious and chronic diseases
The prevalence of infectious and chronic diseases such as cancer, diabetes and cardiovascular disorder is rapidly increasing across Europe. According to the World Health Organization (WHO), the contribution of chronic diseases was about 60% which accounted for the number of deaths. In Europe, the major reason behind the increasing number of chronic diseases is the increasing number of geriatric population. These increasing rates of the diseases are directly proportional to the market growth of POCT devices as they are used in the diagnosis of almost all diseases. We also know that as health degeneration begins with aging, the rate of chronic diseases and factors associated with them also increase with time. However, with increase in disease rate, the healthcare system and status of health is also improving due to awareness and adoption of POCT devices that help in the diagnosis of multiple chronic diseases thereby, driving the market growth.
For instance,
- In October 2017, according to a report published in Springer, 85% of deaths in the European Union (EU) were due to chronic diseases including cancer, cardiovascular disease, chronic respiratory disease, diabetes and mental illness
The growing incidences of chronic diseases in Europe with conditions like cancer, asthma and heart disease among others have improved the usage and awareness about early diagnosis of diseases. This awareness made people buy more healthcare premiums including whole body check-ups regularly that includes almost all the tests. At the same time, the population of chronic diseases is rapidly increasing.
Thus, a major surge in the prevalence of chronic diseases will be acting as a major driver for the market growth as POCT devices can effectively manage the disorder and provide better comfort and treatment for monitoring whenever needed.
- Improved diagnosis-seeking rate
Improved healthcare professionals and regular training sessions for the professionals conducting tests have contributed to the improved diagnosis rates in the region, which includes an increase in the successful diagnosis of chronic diseases like cancer, cardiovascular disease, type 2 diabetes and others. The rate of diagnosis also increases as the burden of disease increases. Healthcare and IT professionals have the power to decrease the likelihood of error and are making attempts to increase the rate of seeking POCT. Along with that, they also help in determining and detecting the risk associated with it. Perhaps, to improve the rate of diagnosis the IT professionals evaluate the user experience also.
To support the POCT process, a methodology was introduced that includes coverage of management, time spent by professionals for diagnosis and evaluation activities that would help in improving the accuracy rate of the information and help in making better decisions in terms of diagnosis. Thus, the efforts by the healthcare and IT professionals, improved training of healthcare professionals, change in the patient care delivery system and improved diagnosis-seeking rate in the region are leading to the market growth.
- Rising preference for homecare testing
Increased demand for homecare testing results in reduced error and safety with ensured quality clinical information that will be available at appropriate time and location and also helps to understand the elder case of a medical emergency. The market has been growing due to rising geriatric population thereby, increasing the demand for homecare testing. With the help of cutting-edge modern technologies, home health care costs have been dramatically reduced and people are being helped effectively. Thus, increased preferences for home healthcare services will boost the demand for POCT devices driving the market growth.
Opportunity
- Strategic initiatives by the market players
The increase in the prevalence of chronic and infectious diseases in Europe requires new and advanced POCT kits and solutions with improved efficacy rate and reduced cycle time due to rise in the geriatric population and also to improve the healthcare management and diagnostics for quality performance. Major market leaders are engaged in full filling the demands of healthcare professionals and spending their time in research to produce better products, kits and reagents.
These strategic initiatives by the companies including acquisition and focused segment product launches are helping them to expand and enhance the product portfolio of the company which will ultimately lead to more revenue generation. Hence, these strategic initiatives by the market players are acting as an opportunity that is helping them to drive market growth.
Restraint/Challenge
- Lack of alignment with test results obtained from laboratories
The POCT results when compared with laboratory testing standards can differ and be performed by clinical personnel who are not trained in clinical laboratory sciences. The standardization and other essential criteria cannot be completed by POCT and this is acting as a major challenge for the market growth.
Given the advantages of POCT research, some downsides are not necessarily considered the safest choice. Owing to the sensitivity and precision associated with laboratory analyzers, clinical laboratory personnel are well aware of the analytical methodologies and are more reliable. In comparison, the test carried out by healthcare personnel rather than laboratory qualified persons resulted in mistakes arising from lack of awareness on the significance of quality management and quality assurance procedures. Thus, more precise and accurate results can be expected from laboratory testing as POCT faces challenges to meet all specific standards of testing due to lack of knowledge.
Recent Developments
- In May 2022, Abbott updated i-STAT software for hospitals and outpatient facilities to provide solution in real-time. The software consists of high efficacy rate, is cost-effective and provides good quality patient care decision-making
- In May 2022, EKF Diagnostics announced the launch of its new EKF Link digital connectivity solution for the secure management of POC analyzers and associated data on one centralized platform
Europe Point of Care Testing (POCT) Market Scope
Europe point of care testing (POCT) market is segmented into product, application, end user, mode of testing and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product
- Instruments
- Consumables & Reagents
- Others
Based on product, the market is segmented into instruments, consumables & reagents and others.
Application
- Blood Glucose
- Cardiac Monitoring
- Coagulation
- Whole Blood Analysis
- Vital Sign Monitoring
- Infectious Disease Testing
- Urine Analysis
- Cholesterol Testing
- Others
Based on application, the market is segmented into blood glucose, cardiac monitoring, coagulation, whole blood analysis, vital sign monitoring, infectious disease testing, urine analysis, cholesterol testing and others.
End User
- Laboratories
- Hospitals
- Clinics
- Ambulatory Centers
- Home Care
- Assisted Living Facilities
- Pharmacies/Drug Stores
- Others
В зависимости от конечного пользователя рынок сегментируется на лаборатории, больницы, клиники, амбулаторные центры, учреждения по уходу на дому, дома престарелых, аптеки и другие.
Режим тестирования
- Тестирование на основе рецепта
- Тестирование без рецепта
По способу тестирования рынок сегментируется на тестирование по рецепту и безрецептурное тестирование.
Канал распространения
- Прямые продажи
- Сторонний дистрибьютор
- Онлайн-продажа
По каналу сбыта рынок сегментируется на прямые продажи, сторонних дистрибьюторов и онлайн-продажи.
Региональный анализ/информация о рынке тестирования в местах оказания медицинской помощи (POCT) в Европе
Проведен анализ европейского рынка тестирования по месту оказания медицинской помощи (POCT), а также предоставлены сведения о размерах рынка и тенденциях по продуктам, сферам применения, конечным пользователям, способам тестирования и каналам сбыта.
Страны, охваченные этим рынком: Германия, Франция, Великобритания, Италия, Испания, Нидерланды, Россия, Швейцария, Турция, Бельгия и остальная Европа. Германия доминирует на европейском рынке тестирования в месте оказания медицинской помощи (POCT) с точки зрения доли рынка и доходов рынка и продолжит процветать в течение прогнозируемого периода. Это связано с возросшей осведомленностью об устройствах POCT в европейском регионе.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые и заменяющие продажи, демографические данные страны, эпидемиология заболеваний и импортно-экспортные тарифы, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы из-за высокой конкуренции со стороны местных и внутренних брендов, а также влияние каналов продаж.
Конкурентная среда и анализ доли рынка тестирования в местах оказания медицинской помощи (POCT) в Европе
Конкурентная среда рынка тестирования в точках оказания помощи содержит подробную информацию о конкурентах. Включены следующие сведения: обзор компании, финансовые показатели компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта и доминирование в применении. Приведенные выше данные относятся только к фокусу компаний на рынке тестирования в точках оказания помощи.
Среди основных игроков, работающих на этом рынке, можно назвать Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Quidel Corporation Trividia Health, Inc., Nova Biomedical, PTS Diagnostics, Trinity Biotech, LumiraDx, Sekisui Diagnostics, Chembio Diagnostics, Inc., BD, Thermo Fisher Scientific Inc., Abbott, Danaher, binx health, Inc., QuantuMDx Group Ltd., Werfen, Thermo Fisher Scientific, Abaxis, EKF Diagnostics и Sysmex Europe SE, а также другие.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE POINT OF CARE TESTING (POCT) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES
5.1.2 IMPROVED DIAGNOSIS-SEEKING RATE
5.1.3 DEMAND FOR WEARABLE OR PORTABLE GLUCOSE MONITORING DEVICES
5.1.4 RISING PREFERENCE FOR HOMECARE TESTING
5.2 RESTRAINTS
5.2.1 LACK OF ACCURACY
5.2.2 HIGH COST OF PRODUCT
5.2.3 LACK OF TRAINING
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
5.3.2 RISING AWARENESS AND GOVERNMENT FUNDING
5.4 CHALLENGES
5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
5.4.2 IMPROPER CARE OF POCT DEVICES
6 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 INSTRUMENTS
6.2.1 MOBILE PLATFORM (SMALL)
6.2.2 FACILITY-BASED PLATFORMS (LARGE POCT PLATFORM)
6.3 CONSUMABLES & REAGENTS
6.4 OTHERS
7 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 BLOOD GLUCOSE
7.3 INFECTIOUS DISEASE TESTING
7.4 CARDIAC MONITORING
7.5 COAGULATION
7.6 WHOLE BLOOD ANALYSIS
7.7 CHOLESTEROL TESTING
7.8 VITAL SIGN MONITORING
7.9 URINE ANALYSIS
7.1 OTHERS
8 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY END USER
8.1 OVERVIEW
8.2 LABORATORIES
8.3 HOSPITALS
8.4 CLINICS
8.5 HOMECARE
8.6 AMBULATORY CENTERS
8.7 ASSISTED LIVING FACILITIES
8.8 PHARMACIES/DRUG STORES
8.9 OTHERS
9 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING
9.1 OVERVIEW
9.2 PRESCRIPTION BASED TESTING
9.3 OTC TESTING
10 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 THIRD PARTY DISTRIBUTOR
10.3 DIRECT SALES
10.4 ONLINE SALES
11 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY COUNTRY
11.1 GERMANY
11.2 U.K.
11.3 FRANCE
11.4 SPAIN
11.5 ITALY
11.6 RUSSIA
11.7 NETHERLANDS
11.8 SWITZERLAND
11.9 TURKEY
11.1 BELGIUM
11.11 REST OF EUROPE
12 EUROPE POINT OF CARE TESTING (POCT) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 F. HOFFMANN-LA ROCHE LTD
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 SIEMENS HEALTHCARE GMBH
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 WERFEN
14.3.1 COMPANY SNAPSHOT
14.3.2 PRODUCT PORTFOLIO
14.3.3 RECENT DEVELOPMENT
14.4 SYSMEX EUROPE SE.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 DANAHER
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 QUIDEL CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 LUMIRAXDX
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BD
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 ABBOTT
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 ABAXIS
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 BINX HEALTH, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 CHEMBIO DIAGNOSTICS SYSTEMS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.13 EKF DIAGNOSTICS
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 NOVA BIOMEDICAL
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 PTS DIAGNOSTICS
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 SEKISUI DIAGNOSTICS
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 TRINITY BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 TRIVIDIA HEALTH, INC.
14.18.1 PRODUCT PORTFOLIO
14.18.2 RECENT DEVELOPMENT
14.19 THERMO FISHER SCIENTIFIC INC. (2021)
14.19.1 COMPANY SNAPSHOT
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 QUANTUMDX GROUP LTD.
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Список таблиц
TABLE 1 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 2 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 3 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY VOLUME, 2020-2029 (MILLION UNITS)
TABLE 4 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 6 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 7 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 8 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 9 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 10 GERMANY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 11 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 12 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 13 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 14 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 15 U.K. POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 16 U.K. INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 17 U.K. POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 U.K. POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 19 U.K. POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 20 U.K. POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 21 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 22 FRANCE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 23 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 25 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 26 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 27 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 28 SPAIN INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 29 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 31 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 32 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 33 ITALY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 34 ITALY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 35 ITALY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 ITALY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 37 ITALY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 38 ITALY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 39 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 40 RUSSIA INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 41 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 42 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 43 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 44 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 45 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 46 NETHERLANDS INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 47 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 48 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 50 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 52 SWITZERLAND INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 53 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 54 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 56 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 58 TURKEY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 59 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 60 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 62 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 63 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 64 BELGIUM INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 66 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 67 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 68 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 69 REST OF EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
Список рисунков
FIGURE 1 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 EUROPE POINT OF CARE TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE POINT OF CARE TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 EUROPE POINT OF CARE TESTING (POCT) MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 EUROPE POINT OF CARE TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE POINT OF CARE TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE POINT OF CARE TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE POINT OF CARE TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 10 RISING POPULARITY AMONG PROFESSIONAL ATHLETES IS EXPECTED TO DRIVE THE EUROPE POINT OF CARE TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2021 TO 2029
FIGURE 11 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE POINT OF CARE TESTING (POCT) MARKET IN 2021 & 2029
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE POINT OF CARE TESTING MARKET
FIGURE 13 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, 2021
FIGURE 14 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 15 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, CAGR (2022-2029)
FIGURE 16 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, LIFELINE CURVE
FIGURE 17 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, 2021
FIGURE 18 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 19 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, CAGR (2022-2029)
FIGURE 20 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 21 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, 2021
FIGURE 22 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, 2022-2029 (USD MILLION)
FIGURE 23 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, CAGR (2022-2029)
FIGURE 24 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, LIFELINE CURVE
FIGURE 25 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, 2021
FIGURE 26 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, 2022-2029 (USD MILLION)
FIGURE 27 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, CAGR (2022-2029)
FIGURE 28 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, LIFELINE CURVE
FIGURE 29 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, 2021
FIGURE 30 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 31 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 32 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 EUROPE POINT OF CARE TESTING (POCT) MARKET : SNAPSHOT (2021)
FIGURE 34 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2021)
FIGURE 35 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2022 & 2029)
FIGURE 36 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2021 & 2029)
FIGURE 37 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT (2022 & 2029)
FIGURE 38 EUROPE POINT OF CARE (POCT) MARKET: COMPANY SHARE 2021 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.